Caspase-3 immunohistochemistry explained

The result is interpreted with the tissue's appearance, clinical details and other markers. It does not independently confirm or exclude cancer, predict a person's outcome or show whether every abnormal cell is dying.

Caspase-3 is an enzyme involved in apoptosis, a controlled process cells use to dismantle themselves. A laboratory may use an antibody that highlights caspase-3 or its activated form. The exact antibody matters, so wording such as ‘cleaved caspase-3’ should not be treated as interchangeable with every caspase-3 stain.

A pathologist considers which cells stain, where the colour appears inside them, how strong it looks and whether internal controls worked. Tissue handling, treatment before sampling and naturally dying cells can all affect the pattern.

Read the result within the final pathology diagnosis rather than as a stand-alone line. Ask whether the laboratory tested total or activated caspase-3, what question the stain was intended to answer, and whether other stains or molecular tests carry more weight for diagnosis or treatment planning.

If the report is preliminary, wait for the integrated interpretation before making care decisions. A second pathology review may be considered when findings are uncertain, unexpected or central to a major treatment choice.

The stain itself is performed on tissue and causes no new symptoms. After a biopsy, follow the procedure team's instructions. Contact them promptly for increasing redness, warmth, swelling, drainage, fever or pain at the sampling site. Seek urgent help for heavy bleeding, severe breathlessness, fainting or rapidly worsening swelling.

Ask: Which cells were positive? Were the controls satisfactory? Does the staining change the final diagnosis? Is it being used for routine diagnosis or to explore treatment effects? Are additional results still pending, and when will the complete report be discussed?